Bigul

Windlas Biotech Ltd - 543329 - Board Meeting Intimation for Notice Of The Board Meeting Scheduled To Be Held On Friday, May 05, 2023

Windlas Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/05/2023 ,inter alia, to consider and approve To consider and approve the audited standalone and consolidated financial results for the quarter and year ended March 31, 2023 and to consider recommendation of dividend, if any, amongst other routine matters.
28-04-2023
Bigul

Windlas Biotech Ltd - 543329 - Submission Of Details Of Extinguishment Pursuant To Provisions Of Regulation 21 Read With Regulation 11 Of The SEBI (Buy-Back Of Securities) Regulations, 2018

Pursuant to the provisions of Regulation 21 read with Regulation 11 of the Buy-back Regulations, the Company has completed the extinguishment of 37,358 (Thirty Seven Thousand Three Hundred Fifty Eight) equity shares bought back under the Buy-back during the period from April 17, 2023 till April 25, 2023. In connection with the same, we are submitting herewith details of extinguishment along with the debit confirmation letter received from the Central Depository Services Limited.
28-04-2023
Bigul

Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares

Submission of daily report in accordance with Regulation 18(i) of the SEBI (Buy-back of Securities) Regulations, 2018
27-04-2023
Bigul

Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares

Submission of daily report in accordance with Regulation 18(i) of the SEBI (Buy-back of Securities) Regulations, 2018
24-04-2023
Bigul

Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
24-04-2023
Bigul

Windlas Biotech Ltd - 543329 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyWindlas Biotech Ltd 2CIN NO.L74899UR2001PLC033407 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.11 4Highest Credit Rating during the previous FY A+ 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)ICRA LIMITED 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Ananta Narayan Panda Designation: Company Secretary EmailId: [email protected] Name of the Chief Financial Officer: Komal Gupta Designation: CFO and CEO EmailId: [email protected] Date: 24/04/2023 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
24-04-2023
Bigul

Windlas Biotech Ltd - 543329 - Submission Of Details Of Extinguishment Pursuant To Provisions Of Regulation 21 Read With Regulation 11 Of The SEBI (Buy-Back Of Securities) Regulations, 2018

Pursuant to the provisions of Regulation 21 read with Regulation 11 of the Buy-back Regulations, the Company has completed the extinguishment of 18,522 (Eighteen Thousand Five Hundred and Twenty Two) equity shares bought back under the Buy-back during the period from April 06, 2023 till April 13, 2023. In connection with the same, we are submitting herewith details of extinguishment along with the debit confirmation letter received from the Central Depository Services Limited and Certificate of Extinguishment for your records.
20-04-2023
Bigul

Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares

Submission of daily report in accordance with Regulation 18(i) of the SEBI (Buy-back of Securities) Regulations, 2018
20-04-2023
Bigul

Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares

Submission of daily report in accordance with Regulation 18(i) of the SEBI (Buy-back of Securities) Regulations, 2018
17-04-2023
Bigul

Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares

Submission of daily report in accordance with Regulation 18(i) of the SEBI (Buy-back of Securities) Regulations, 2018
12-04-2023
Next Page
Close

Let's Open Free Demat Account